154 related articles for article (PubMed ID: 29344971)
1. Clear cell carcinomas of the ovary and kidney: clarity through genomics.
Ji JX; Wang YK; Cochrane DR; Huntsman DG
J Pathol; 2018 Apr; 244(5):550-564. PubMed ID: 29344971
[TBL] [Abstract][Full Text] [Related]
2. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
[TBL] [Abstract][Full Text] [Related]
4. SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary.
Jiang T; Diao X; Ding M; Niu X; Wang C; Qi Y; Jia W; Pang L; Hu W; Zou H; Li F
J Mol Histol; 2021 Jun; 52(3):539-544. PubMed ID: 33608777
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.
Improta G; Pettinato A; Høgdall E; Santeusanio G; Vatrano S; Fraggetta F; Zannoni GF
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):631-636. PubMed ID: 29629954
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
8. The molecular pathology of cancer: from pan-genomics to post-genomics.
Huntsman DG; Ladanyi M
J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
[TBL] [Abstract][Full Text] [Related]
9. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
10. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
11. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
Adeniran AJ; Shuch B; Humphrey PA
Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities of molecular diagnosis of renal cell carcinoma].
Junker K
Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
[TBL] [Abstract][Full Text] [Related]
14. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications.
Rydzanicz M; Wrzesiński T; Bluyssen HA; Wesoły J
Cancer Lett; 2013 Dec; 341(2):111-26. PubMed ID: 23933176
[TBL] [Abstract][Full Text] [Related]
15. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
16. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF Complex Genomic Alterations as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Multiple Cancers.
Wang D; Wang J; Zhou D; Wu Z; Liu W; Chen Y; Chen G; Zhang J
Cancer Immunol Res; 2023 May; 11(5):646-656. PubMed ID: 36848524
[TBL] [Abstract][Full Text] [Related]
19. The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma.
He YH; Chen C; Shi Z
J Cell Physiol; 2018 Jun; 233(6):4458-4465. PubMed ID: 29215721
[TBL] [Abstract][Full Text] [Related]
20. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
